SUPERNUS PHARMACEUTICALS, INC.·4

Feb 27, 5:04 PM ET

Barlow Carrolee 4

4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 27, 2024

Insider Transaction Report

Form 4
Period: 2024-02-23
Transactions
  • Award

    Common Stock

    2024-02-23+3,88617,201 total
  • Disposition to Issuer

    Restricted Stock Units

    2024-02-233,8860 total
    Common Stock (3,886 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
  • [F2]These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024.

Documents

1 file
  • 4
    tm247055-16_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT